Alpha-Stim

Alpha-Stim

Celebrating 27 years
1981-2008

Select Your Language

Espanol Francais
Italiano Korean
Chinese Nederlands
Turkish Norwegian

EPI

2201 Garrett Morris Parkway
Mineral Wells, TX 76067-9034
USA
1-800-FOR-PAIN (367-7246)
in USA & CANADA
Tel: (940) 328-0788
Fax: (940) 328-0888
Email

© Copyright 2008 Electromedical Products International, Inc.
All rights reserved.

Alpha-Stim® is registered in the US Patent and Trademark office and worldwide.

SGS AIS Award wego U.S. Chamber of Commerce Member 2008
US Government Federal Supply Schedule
Contract Number for DOD and VA: V797P-4800a

Research Abstracts

 

Smith, Ray B. Is microcurrent stimulation effective in pain management? An additional perspective. American Journal of Pain Management, 11(2):62-66, 2001.


This is a peer-reviewed analysis of 2,500 consecutive survey forms from warranty cards completed by patients who were prescribed Alpha-Stim microcurrent electrical therapy (MET) and cranial electrotherapy stimulation (CES). The only inclusion criteria were that the patients used their Alpha-Stim for at least 3 weeks. 1,949, or 78% of the total listed pain as their primary diagnosis. Of those, 93% claimed significant pain reduction of greater than 25% improvement, ranging from a low of 82% in chronic regional pain syndrome (RSD) to a high of 98% in those suffering from migraine headaches and 100% in carpal tunnel syndrome.  72% of the patients were female. The age ranged from 15 to 92 years with a mean of 50 years. The length of use ranged from the 3 week minimum cutoff period to 5 years in 2 cases. The average period of use was 14.68 weeks, or just over 3 1/2 months. The results reported by these patients were only 2% off a previous physician survey of 500 patients (the patients self-reports giving slightly higher ratings overall) reported in the book, The Science behind Cranial Electrotherapy Stimulation by Dr. Daniel L. Kirsch.

Condition

N

Slight
<24%

Fair
25-49%

Moderate
50-74%

Marked
75-100%

Significant
>25%

Pain (all cases)

1949

136
6.98%

623
31.97%

741
38.02%

449
23.04%

1813
93.02%

Back Pain

403

20
4.96%

109
27.05%

157
38.96%

117
29.03%

383
95.04%

Cervical Pain

265

18
6.79%

69
26.04%

125
47.17%

53
20.00%

247
93.21%

Hip/Leg/Foot Pain

160

6
3.75%

43
26.88%

53
33.13%

58
36.25%

154
96.25%

Shoulder/Arm/Hand Pain

150

13
8.67%

41
27.33%

63
42.00%

33
22.00%

137
91.33%

Carpal Tunnel

25

0
0.00%

5
20.00%

17
68.00%

3
12.00%

25
100.00%

Arthritis Pain

188

11
5.85%

51
27.13%

88
46.81%

38
20.21%

177
94.15%

TMJ Pain

158

17
10.76%

60
37.97%

60
37.97%

21
13.29%

141
89.24%

Myofascial Pain

62

6
9.68%

18
29.03%

18
29.03%

20
32.26%

56
90.32%

RSD

55

10
18.18%

16
29.09%

19
34.55%

10
18.18%

45
81.82%

Fibromyalgia (alone)

142

13
9.15%

53
37.32%

52
36.62%

24
16.90%

129
90.85%

Fibromyalgia (with other)

363

33
9.09%

131
36.09%

152
41.87%

47
12.95%

330
90.91%

Migraine

118

2
1.69%

49
41.53%

30
25.42%

37
31.36%

116
98.31%

Headaches (all other)

112

20
17.86%

30
26.79%

24
21.43%

38
33.93%

92
82.14%

Psychological (all cases)

723

61
8.44%

175
24.20%

237
32.78%

250
34.58%

662
91.56%

Anxiety (alone)

128

13
10.16%

29
22.66%

42
32.81%

44
34.38%

115
89.84%

Anxiety (with other)

370

33
8.92%

85
22.97%

122
32.97%

130
35.14%

337
91.08%

Anxiety/Depression

58

3
5.17%

19
32.76%

19
32.76%

17
29.31%

55
94.83%

Depression (alone)

53

7
13.21%

11
20.75%

23
43.40%

12
22.64%

46
86.79%

Depression (with other)

265

29
10.94%

61
23.02%

93
35.09%

82
30.94%

236
89.06%

Stress

123

6
4.88%

30
24.39%

39
31.71%

48
39.02%

117
95.12%

Chronic Fatigue

50

3
6.00%

30
60.00%

10
20.00%

7
14.00%

47
94.00%

Insomnia

163

10
6.13%

47
28.83%

47
28.83%

59
36.20%

153
93.87%

Figure 1. Self-reported results of 2,500 patients who used Alpha-Stim technology for at least 3 weeks.

download full text article

Return to Research and Reviews